Renal Cancer - Results from #5920

Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes December 2, 2015

Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective December 2, 2015

Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma December 2, 2015

Chemopreventive efficacy of hesperidin against chemically induced nephrotoxicity and renal carcinogenesis via amelioration of oxidative stress and modulation of multiple molecular pathways November 26, 2015

The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy November 25, 2015

Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer November 25, 2015

AGS16F is a Novel Antibody Drug Conjugate Directed Against ENPP3 for the Treatment of Renal Cell Carcinoma November 25, 2015

The heterogeneity of radiologic response with anti-PD-1/PD-L1 therapy in metastatic Renal Cell Carcinoma (mRCC) November 24, 2015

Opdivo to treat advanced form of kidney cancer approved by the FDA November 24, 2015

Long-term survival following multidisciplinary treatment of metastatic sarcomatoid renal cell carcinoma: a case report November 23, 2015

Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma November 23, 2015

Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhib November 23, 2015

Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients November 23, 2015

Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis November 23, 2015

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC) November 23, 2015

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma November 20, 2015

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma November 20, 2015

The radiogenomic risk score stratifies outcomes in a renal cell cancer phase 2 clinical trial November 19, 2015

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma. November 19, 2015

Renal cell carcinoma: review of etiology, pathophysiology and risk factors November 19, 2015

Page 297 of 456